A recent study suggests that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Published data in a major medical journal demonstrates that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such medications should be cognizant of the danger of quick weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain suggests a return to original weight in about 18 months.
Analyzing Approaches
The analysis, which examined dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
The team point out that individuals who lose weight through dieting usually see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Nutrition scientists propose the mode of action of the injections accounts for the accelerated regain.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating a significant risk."
An Ongoing Issue?
Health authorities advise the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts say that, due to the high risk of relapse, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who note that the results "underscore the long-term nature of excess weight," akin to managing diseases like high blood pressure.
User Experiences
Individuals who have stopped the jabs report a intense resurgence of hunger.
"I experienced something flipping and you're instantly extremely hungry," said an individual.
This challenge is worsened if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Significant Use
Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is greater among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are effective agents for weight loss, they are not a permanent fix and lasting health benefits hinges on ongoing behavioural management.
